Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 6,317 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolism and Nutrition Disorders Clear all

Conditions: Obesity
Interventions: Biospecimen collection; Other
Lead sponsor: CorEvitas; Network
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2099
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Obesity, Ketogenic Dieting, Metabolic Syndrome, Bipolar Disorder, Schizophrenia, Weight Gain, Psychotropic Agents Causing Adverse Effects in Therapeutic Use, Brain Metabolic Disorder
Interventions: LCHF, Ketogenic Diet; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obesity
Interventions: leuprolide acetate, Estradiol Transdermal, progressive resistance exercise training; Drug · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Obesity
Interventions: Mealtime Supports, Usual Exposure; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: Not listed
Enrollment: 810 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 4
States / cities: Ann Arbor, Michigan • East Lansing, Michigan • Jackson, Michigan + 1 more

Conditions: Hyperinsulinemia, Insulin Resistance, Obesity
Interventions: metformin and rosiglitazone; Drug
Lead sponsor: New York Medical College; Other
Eligibility: 35 Years to 55 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Urinary Incontinence, Vitamin D Deficiency
Interventions: Vitamin D3 50,000 IU, Placebo; Dietary Supplement · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 50 Years and older · Female only
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Body Weight Changes, Weight Loss, Healthy Diet, Obesity
Interventions: Video Conferencing Health Coaching with devices, Video Conferencing Health Coaching with no devices; Behavioral
Lead sponsor: Coastal Carolina University; Other
Eligibility: 20 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Bradenton, Florida

Conditions: Obesity
Interventions: Diet, Exercise, Weight Loss and Exercise; Behavioral · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 65 Years to 85 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Overweight and Obesity
Interventions: One-on-one Session, Self-monitoring, Feedback; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 502 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Insulin Resistance
Interventions: HE3286; Drug
Lead sponsor: Harbor Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Baton Rouge, Louisiana • San Antonio, Texas

Conditions: Obesity, Fertility
Interventions: LOVAZA, GnRH; Dietary Supplement · Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Obesity
Interventions: Not listed
Lead sponsor: Janelle Vaughns; Other
Eligibility: 12 Years to 20 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Chronic Kidney Disease, Hyperparathyroidism, Secondary, Vitamin D Deficiency
Interventions: CTAP101 30 μg capsules, Sugar pill to CTAP101 30 μg capsules; Drug · Other
Lead sponsor: OPKO IP Holdings II, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Bannockburn, Illinois

Conditions: Obesity
Interventions: MOVE; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 60 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Colon Cancer, Lung Cancer, Atrial Fibrillation, Diabetes Type 2, Obesity, Breast Cancer, Graves Disease, Osteoarthritis, Celiac Disease, Myocardial Infarction, Prostate Cancer
Interventions: SNP analysis; Genetic
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity
Interventions: FB Professional LED Red light therapy, Effects of Red Light LED Therapy on Body Contouring; Device
Lead sponsor: Manamed Inc.; Industry
Eligibility: 18 Years to 77 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: New Port Richey, Florida

Conditions: Type2 Diabetes, Type 2 Diabetes Mellitus, Insulin Sensitivity, Insulin Resistance, Depression, Adolescent Obesity
Interventions: Cognitive-behavioral therapy group, Health education group; Behavioral
Lead sponsor: Colorado State University; Other
Eligibility: 12 Years to 17 Years · Female only
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Obesity, Diabetes, Metabolic Disorders
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 8 Years to 65 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2055
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Type 2 Diabetes Mellitus, Obesity, Overweight
Interventions: Semaglutide, Dulaglutide; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 120,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Insulin Resistance, Normal Weight,Healthy Controls
Interventions: Ghrelin infusion to assess effects on insulin sensitivity; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obesity
Interventions: LY3532226, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Daytona Beach, Florida • Dallas, Texas • Madison, Wisconsin

Conditions: Obesity, Metabolic Syndrome X
Interventions: Metformin, Orlistat, Topiramate, Placebo; Drug
Lead sponsor: University of Iowa; Other
Eligibility: 40 Years to 75 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: HIV Infections, HIV Wasting Syndrome
Interventions: Multivitamin and mineral supplements, Peptamen, NuBasics; Dietary Supplement
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 536 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 1998
U.S. locations: 17
States / cities: San Francisco, California • Denver, Colorado • Washington D.C., District of Columbia + 11 more

Conditions: Obesity, Nutrition Poor
Interventions: Increase Minimum Wage to $15-an-hour, No Increase in Minimum Wage; Other
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years and older
Enrollment: 974 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

PPDTM CorEvitasTM Obesity (OBR) Drug Effectiveness and Safety Registry

Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness

Prevention of Obesity in Women Via Estradiol Regulation

Effectiveness of Differing Levels of Support for Family Mealtimes on Obesity Prevention Among Head Start Preschools

EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance

Vitamin D Supplementation in Older Adults With Urinary Incontinence

A Remote Delivered Lifestyle Therapeutics Program

Weight Loss and Exercise in Obese, Physically Limited, Older Women and Men

Promoting Lifestyle Change Via Tailored mHealth Feedback to Improve Health

Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult Subjects

Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women

Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery

Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency

Motivation for Exercise and Physical Activity Adherence

Predictive Genetic Risk Assessment Trial

Effects of Red Light LED Therapy on Body Contouring

Depression & Insulin Sensitivity in Adolescents

Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults

Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

Ghrelin and Insulin Resistance

A Study of LY3532226 in Participants With Obesity

Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity

A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements

A Natural Experiment Evaluating the Effect of a Minimum Wage Increase on Obesity and Diet-related Outcomes